Clinical Trial Update: Bioequivalence Study of Entecavir Tablets and Baraclude® Under Fasting Condition in Chinese Healthy Volunteers [NA]

View source ↗

Summary

The document reports completion of a fasting-state bioequivalence study comparing Entecavir tablets to Baraclude in healthy Chinese volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)
• Entecavir tablets (Entecavir)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Chronic Hepatitis b | NA | Status: COMPLETED